SMARCA4 and breast cancer: A more recent study showed that an antisense lncRNA TGFB2-AS1 suppresses TGFB2 transcription in breast cancer cells through sequestering SMARCA4 (a SWI/SNF complex catalytic subunit) away from the TGFB2 promoter [39].